These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5071738)

  • 1. Canine electrocardiographic and cardiac electrophysiologic changes induced by procainamide.
    Rosen MR; Gelband H; Hoffman BF
    Circulation; 1972 Sep; 46(3):528-36. PubMed ID: 5071738
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophysiologic effects of procaine amide in patients with intraventricular conduction delay.
    Scheinman MM; Weiss AN; Shafton E; Benowitz N; Rowland M
    Circulation; 1974 Mar; 49(3):522-9. PubMed ID: 4591547
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of plasma drug level and the presence of conduction disease on the electrophysiologic effects of procainamide.
    Wyse DG; McAnulty JH; Rahimtoola SH
    Am J Cardiol; 1979 Mar; 43(3):619-26. PubMed ID: 420112
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Comparison of the effects of mexiletine, lignocaine and procainamide on canine Purkinje fibres.
    Allen JD; Arnold JM
    J Physiol; 1974 Jan; 236(1):26P-28P. PubMed ID: 4818502
    [No Abstract]   [Full Text] [Related]  

  • 5. Aberrancy: electrophysiologic aspects.
    Singer DH; Ten Eick RE
    Am J Cardiol; 1971 Oct; 28(4):381-401. PubMed ID: 4938003
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of procaine amide on the electrophysiologic properties of the canine ventricular conducting system.
    Rosen MR; Merker C; Gelband H; Hoffman BF
    J Pharmacol Exp Ther; 1973 Jun; 185(3):438-46. PubMed ID: 4712643
    [No Abstract]   [Full Text] [Related]  

  • 7. Electrophysiology and pharmacology of cardiac arrhythmias. vii. Cardiac effects of quinidine and procaine amide. B.
    Hoffman BF; Rosen MR; Wit AL
    Am Heart J; 1975 Jul; 90(1):117-22. PubMed ID: 1094818
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of arrhythmias: basic considerations.
    Lasseter KC
    Med Clin North Am; 1971 Mar; 55(2):435-44. PubMed ID: 4926059
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical pharmacology and therapeutic applications of the antiarrhythmic drugs.
    Mason DT; Spann JF; Zelis R; Amsterdam EA
    Clin Pharmacol Ther; 1970; 11(4):460-80. PubMed ID: 4913865
    [No Abstract]   [Full Text] [Related]  

  • 10. Epicardial mapping of polymorphous ventricular tachycardias induced in the canine heart with procainamide.
    Murakawa Y; Inoue H; Toda I; Nozaki A; Kawakubo K; Sugimoto T
    Am Heart J; 1988 May; 115(5):1037-42. PubMed ID: 3364336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of procainamide on conduction in anisotropic canine ventricular myocardium.
    Kadish AH; Spear JF; Levine JH; Moore EN
    Circulation; 1986 Sep; 74(3):616-25. PubMed ID: 3742759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic properties of procainamide in man.
    Josephson ME; Caracta AR; Ricciutti MA; Lau SH; Damato AN
    Am J Cardiol; 1974 May; 33(5):596-603. PubMed ID: 4820891
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiarrhythmic drugs.
    Rosen MR; Gelband H
    Am Heart J; 1971 Mar; 81(3):428-36. PubMed ID: 4926360
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrophysiologic and antiarrhythmic activities of 4-amino-N-[2-(diethylamino)ethyl]-3,5-dimethylbenzamide, a sterically hindered procainamide analogue.
    Robertson DW; Beedle EE; Wilson H; Parli CJ; Smallwood JK; Steinberg MI
    J Med Chem; 1988 Jul; 31(7):1290-5. PubMed ID: 3385724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.
    Jaillon P; Winkle RA
    Circulation; 1979 Dec; 60(6):1385-94. PubMed ID: 91451
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent advances in electrophysiology of antiarrhythmic drugs.
    Bassett AL; Wit AL
    Prog Drug Res; 1973; 17():33-58. PubMed ID: 4593392
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of procainamide infusions.
    Lima JJ; Goldfarb AL; Conti DR; Golden LH; Bascomb BL; Benedetti GM; Jusko WJ
    Am J Cardiol; 1979 Jan; 43(1):98-105. PubMed ID: 758776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic effects of procainamide in subtherapeutic to therapeutic doses on human atrioventricular conduction system.
    Ogunkelu JB; Damato AN; Akhtar M; Reddy CP; Caracta AR; Lau SH
    Am J Cardiol; 1976 Apr; 37(5):724-31. PubMed ID: 773160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.
    Koch-Weser J; Klein SW; Foo-Canto LL; Kastor JA; DeSanctis RW
    N Engl J Med; 1969 Dec; 281(23):1253-60. PubMed ID: 4900236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.